Article info
PDFEBM analysis
General medicine
Early experience with the FDA’s regulatory review of novel gene therapies
- Correspondence to Dr Jeremy Puthumana, Yale University School of Medicine, New Haven, Connecticut, USA; jeremy.puthumana{at}yale.edu
Citation
Early experience with the FDA’s regulatory review of novel gene therapies
Publication history
- Accepted September 24, 2021
- First published October 11, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (16 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.